Four Signs That a Medtech Firm Needs To Reinvent Itself (slideshow)

[Photo Credit: iStockphoto.com]

 By Arundhati Parmar, Senior Editor, MD+DI
[email protected]
 

Change or die is a cliché. But it also just happens to be an eternal business truth.

As the medtech world is facing numerous challenges, be it slow-growing markets, difficult regulatory and reimbursement environments or the device tax - it is increasingly important to be vigilant for signs that a business or parts of a business is in trouble and adapt.

Frost & Sullivan's Venkat Rajan, principal analyst, who leads the firm's analysis of the medical device sector, believes that there are at least four troubling signs that should indicate to executives that a thorough reinvention of their business model is needed. In an interview, Rajan discusses what those are and what some companies did when faced with them. Here is a slideshow based on that discussion:

[Photo Credit: iStockphoto.com user eric223]